These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 36286856

  • 1. [Modern view on the complement system role in membranous nephropathy].
    Kamyshova ES, Semeryuk TA, Bobkova IN.
    Ter Arkh; 2022 Aug 04; 94(6):772-776. PubMed ID: 36286856
    [Abstract] [Full Text] [Related]

  • 2. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA, Mezzina N, Trezzi B, Ghiggeri GM, Radice A.
    Clin Exp Immunol; 2016 Feb 04; 183(2):157-65. PubMed ID: 26459770
    [Abstract] [Full Text] [Related]

  • 3. The role of complement in membranous nephropathy.
    Ma H, Sandor DG, Beck LH.
    Semin Nephrol; 2013 Nov 04; 33(6):531-42. PubMed ID: 24161038
    [Abstract] [Full Text] [Related]

  • 4. Is primary membranous nephropathy a complement mediated disease?
    Reinhard L, Stahl RAK, Hoxha E.
    Mol Immunol; 2020 Dec 04; 128():195-204. PubMed ID: 33142137
    [Abstract] [Full Text] [Related]

  • 5. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
    Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, Brandt S, Kölling M, Wegmann U, Kiss B, Pál G, Gál P, Wüthrich RP, Wuhrer M, Beck LH, Salant DJ, Lambeau G, Kistler AD.
    J Clin Invest; 2021 Mar 01; 131(5):. PubMed ID: 33351779
    [Abstract] [Full Text] [Related]

  • 6. The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.
    Manral P, Caza TN, Storey AJ, Beck LH, Borza DB.
    Front Immunol; 2022 Mar 01; 13():952235. PubMed ID: 35874690
    [Abstract] [Full Text] [Related]

  • 7. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
    Zhao Y, Cai M, Jiang Z, Dong B, Yan Y, Wang Y, Zuo L.
    Ren Fail; 2022 Dec 01; 44(1):428-433. PubMed ID: 35272568
    [Abstract] [Full Text] [Related]

  • 8. [Membranous nephropathy].
    Hanset N, Ronco P, Plaisier E.
    Rev Prat; 2021 Jan 01; 71(1):85-89. PubMed ID: 34160953
    [Abstract] [Full Text] [Related]

  • 9. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN, Lai TS, Wu CF, Fu TY, Chou YH, Chiu YL, Lin WC, Chiang WC, Chen YM, Wu MS.
    J Formos Med Assoc; 2019 May 01; 118(5):898-906. PubMed ID: 30639075
    [Abstract] [Full Text] [Related]

  • 10. The fate of immune complexes in membranous nephropathy.
    Xu J, Hu H, Sun Y, Zhao Z, Zhang D, Yang L, Lu Q.
    Front Immunol; 2024 May 01; 15():1441017. PubMed ID: 39185424
    [Abstract] [Full Text] [Related]

  • 11. Circulating antibodies to α-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy.
    Kimura Y, Miura N, Debiec H, Morita H, Yamada H, Banno S, Ronco P, Imai H.
    Clin Exp Nephrol; 2017 Feb 01; 21(1):117-126. PubMed ID: 26830547
    [Abstract] [Full Text] [Related]

  • 12. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy.
    Hayashi N, Okada K, Matsui Y, Fujimoto K, Adachi H, Yamaya H, Matsushita M, Yokoyama H.
    Nephrol Dial Transplant; 2018 May 01; 33(5):832-840. PubMed ID: 28992353
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of membranous nephropathy: a new paradigm in evolution.
    Glassock RJ.
    Contrib Nephrol; 2013 May 01; 181():131-42. PubMed ID: 23689575
    [Abstract] [Full Text] [Related]

  • 14. Unmet challenges in membranous nephropathy.
    Salant DJ.
    Curr Opin Nephrol Hypertens; 2019 Jan 01; 28(1):70-76. PubMed ID: 30451735
    [Abstract] [Full Text] [Related]

  • 15. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment.
    Lai WL, Yeh TH, Chen PM, Chan CK, Chiang WC, Chen YM, Wu KD, Tsai TJ.
    J Formos Med Assoc; 2015 Feb 01; 114(2):102-11. PubMed ID: 25558821
    [Abstract] [Full Text] [Related]

  • 16. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K.
    Rev Med Interne; 2016 Oct 01; 37(10):674-679. PubMed ID: 27236434
    [Abstract] [Full Text] [Related]

  • 17. Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.
    Borza DB.
    Front Immunol; 2016 Oct 01; 7():157. PubMed ID: 27199983
    [Abstract] [Full Text] [Related]

  • 18. Membranous nephropathy.
    Dantas M, Silva LBB, Pontes BTM, Dos Reis MA, de Lima PSN, Moysés Neto M.
    J Bras Nefrol; 2023 Oct 01; 45(2):229-243. PubMed ID: 37527529
    [Abstract] [Full Text] [Related]

  • 19. Novel Biomarkers in Membranous Nephropathy.
    Liu Q, Liu J, Lin B, Zhang Y, Ma M, Yang M, Qin X.
    Front Immunol; 2022 Oct 01; 13():845767. PubMed ID: 35529848
    [Abstract] [Full Text] [Related]

  • 20. The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets.
    So BYF, Chan GCW, Yap DYH, Chan TM.
    Front Immunol; 2022 Oct 01; 13():1009864. PubMed ID: 36353636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.